Home International Cooperation Tags

View the Latest: International Cooperation

Filter

List Grid

11 - 20 of 72 Results

  • The G20 and development assistance for health: historical trends and crucial questions to inform a new era

    Perspective

    In this article for The Lancet, KFF's Jennifer Kates and 19 co-authors examine trends in the provision and receipt of development assistance for health (DAH), particularly for the G20 countries. The article looks at key questions facing leaders of the G20 countries, including how to best focus DAH for equitable health gains, how to deliver DAH to strengthen health systems, and how to support domestic resource mobilization and tranformative partnerships for sustainable impact.

  • The Dangers of Vaccine Disillusionment

    Perspective

    In this Foreign Affairs article, Josh Michaud and Jen Kates lay out the challenges in vaccinating people in low-income countries around the world and review early plans to ensure safe and effective vaccines are made available and delivered to people across the globe.

  • U.S. Global Health Budget Tracker

    Feature

    This tracker provides regularly updated information on U.S. government funding for global health. It includes historical trends and tracks funding levels for U.S. global health efforts through bilateral and multilateral contributions and by program area and agency.

  • Putting U.S. Global COVID-19 Vaccine Donations in Context

    Policy Watch

    While some have praised the most recent U.S. donation announcement as an important development, others have said the U.S. could do much more, pointing to the large supply of doses the U.S. is building up and the slowing demand for vaccinations in the country.  In this policy watch, we sought to put the U.S. pledge of 80 million doses in further context.

  • Civil Society Inclusion in a New Financial Intermediary Fund: Lessons from Current Multilateral Initiatives

    Issue Brief

    To help inform ongoing global discussions about the creation of a new financing mechanism for pandemic preparedness and response, including questions about its governance and operations and the extent to which civil society will be formally included, we analyzed 14 major multilateral global health and related institutions to assess how civil society has been engaged in their governance, implementation/programming, and monitoring.

  • The COVAX Humanitarian Buffer for COVID-19 Vaccines: Review and Assessment of Policy Implications

    Issue Brief

    In this Issue Brief we review and assess the COVAX Humanitarian Buffer mechanism, which is part of the effort to share Covid vaccines globally. The Buffer is intended to direct vaccines to vulnerable people like refugees and others facing humanitarian emergencies during the pandemic, and was supported by the US and many other donors and organizations. However, it faced many challenges such as liability and indemnification issues for using newly developed vaccines, restricted access to vaccines and funding, and difficult and complex application, review, and implementation processes. We discuss these challenges and also consider implications of the Buffer experience for future pandemic preparedness and response efforts.

  • Global COVID-19 Vaccine Equity: U.S. Policy Options and Actions to Date

    Issue Brief

    This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies. We summarize what the administration has done to date in these areas and policy issues related to each.

  • Global COVID-19 Vaccine Access: A Snapshot of Inequality

    Policy Watch

    This policy watch examines global access to COVID-19 vaccines by country income level, assessing country income levels' shares of purchased doses and potential vaccination coverage, while also looking closely at the potential impact of COVAX in addressing vaccine access disparity between high-income and low- and middle-income countries.